Organ Health Publications
Read Article
Resource Library
Natera Resource Hub - your source for articles and videos.
-
-
ctDNA-based molecular residual disease and survival in resectable colorectal cancer
Nakamura, et al. Nature Medicine 2024
Read Publication
-
Prospera Kidney MD Brochure
Read More
-
Renasight Patient Brochure
Discover how Renasight can provide valuable information about your kidney health.
Read More
-
Have a question or comment?
Contact Us -
Why Prospera Surveillance Brochure
The Prospera non-invasive blood test can comprehensively identify all types of active rejection with great precision.
Read More
-
Elevations of dd-cfDNA before bpAR ProActive Study Publication with Supplement April 2024
Bromberg, et al. Transplantation 2024
Read Publication
-
Renasight Provider Brochure
Learn about Renasight genetic testing and how it can provide valuable information for patient management of kidney disease.
Read More
-
How Dr. Yasir Qazi embraced cell-free DNA surveillance, an unaffected approach due to the recent CMS update
Hear from our ProActive Study Investigator In this episode of our Inside the ProActive Study Podcast, Dr. Yasir Qazi talks to us about: • His dd-cfDNA “surveillance journey” and protocol development.
Watch Video
-
How Dr. Yasir Qazi embraced cell-free DNA surveillance, an unaffected approach due to the recent CMS update - Audio Only
Hear from our ProActive Study Investigator In this episode of our Inside the ProActive Study Podcast, Dr. Yasir Qazi talks to us about his dd-cfDNA “surveillance journey” and protocol development.
Listen Now
-
How Dr. Matthew Cooper leverages dd-cfDNA to replace protocol biopsies for surveillance, in-line with ASTS recommended use
In this episode of our Inside the ProActive Study Podcast, Dr. Matthew Cooper shares his insights on: • Utilizing cfDNA alongside DSA and biopsies before implementing his dd-cfDNA surveillance protoc
Watch Video
-
How Dr. Matthew Cooper leverages dd-cfDNA to replace protocol biopsies for surveillance, in-line with ASTS recommended use
In this episode of our Inside the ProActive Study Podcast, Dr. Matthew Cooper shares his insights on: • Utilizing cfDNA alongside DSA and biopsies before implementing his dd-cfDNA surveillance...
Listen Now
-
How Dr. Millie Samaniego bridged the gap between study use and routine care by extending protocolized use
In this episode of our Inside the ProActive Study Podcast, Dr. Millie Samaniego-Picota tells us about: • Her experience expanding the ProActive Study Protocol schedule to all her patients • How her
Watch Video
-
How Dr. Millie Samaniego bridged the gap between study use and routine care by extending protocolized use
In this episode of our Inside the ProActive Study Podcast, Dr. Millie Samaniego-Picota tells us about: • Her experience expanding the ProActive Study Protocol schedule to all her patients • How her
Listen Now
-
Inside the ProActive Study- How Dr Sanjeev Akkina and Dr. Jessica Coleman approach the continuity of transplant recipient care
Watch Video
-
Inside the ProActive Study- How Dr Sanjeev Akkina and Dr. Jessica Coleman approach the continuity of transplant recipient care podcast
Listen Now
-
How Dr. Anand championed a surveillance protocol informed by his deep experience and research
Watch Video
-
How Dr. Anand championed a surveillance protocol informed by his deep experience and research
Listen Now
-
How Dr. Batarse advocates for his patients upon early recognition of subtle rejection using cfDNA
Watch Video
-
How Dr. Batarse advocates for his patients upon early recognition of subtle rejection using cfDNA
Listen Now
-
Multi-Institutional Study Evaluating the Role of Early Circulating Tumor DNA Dynamics During Treatment With Immune Checkpoint Inhibitors in
Ma VT., Zhou AY., Forati A., et al. JCO PO 2026
Read Publication
-
Longitudinal ctDNA monitoring for post-surgical disease surveillance in patients with stage I-IIIB melanoma
Ansstas G., Khaddour K., Sudhaman S., et al. CCR. 2026
Read Publication
-
Sensitivity of Circulating Tumor DNA for Detection of Minimal Residual Disease Recurrence or Relapse in Patients With Melanoma
Steimle AK., Harris MS, Forati A, et al. JCO OA. 2026
Read Publication
-
Circulating Tumor DNA Predicts Response After Definitive Radiation Therapy for Merkel Cell Carcinoma
Murchison, K., Camargo, A., Margalit, D., et al. Adv. Radiat. Oncol. 2026
Read Publication
-
Genomic profiling guided therapy for synchronous SCC and CLL of the parotid gland: a rare case report
Dahiya, R., Weiss, N., Wilson, P., et al. J Surg Case Rep. 2025
Read Publication
-
Have a question or comment?
Contact Us -
Personalized Circulating tumor DNA assay to assess long-term clinical benefit in patients with advanced melanoma
Martinez-Villa C, Teixido C, Martin R, et al. Cancers 2025
Read Publication
-
Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management
Akaike T, Thakuria M, Silk AW, et al. J Am Acad Dermatol. 2025
Read Publication
-
ctDNA Dynamics Identifies Pseudoprogression in a Metastatic Melanoma Patient Treated With Nivolumab/Relatlimab
Steimle AK, Cho SY, Menon N, et al. Journal of Immunotherapy 2025
Read Publication
-
Circulating Tumor DNA in High‐Risk Stage II/III Cutaneous Melanoma: A Feasibility Study
Rhodin KE, O’Connor MH, Therien A, et al. Ann. Surg. Oncol. 2025
Read Publication
-
Signatera Publications
Read Article
-
Understanding Your Risk: The Role of Hereditary Cancer Testing in Prevention
Read Article
-
Expanded eligibility for Natera’s Financial Assistance Program
Read Article
-
Prospera - Increased Risk Result Video
Please watch this short video explaining what your results may mean for you.
Watch Video
-
Dynamics of Tumor-informed Circulating Tumor DNA and Association with Clinical Responses to Enfortumab and Pembrolizumab in Patients with Lo
. Vlachou, B.A. Johnson 3rd, M. Kates et al, Eur Urol Open Sci (2025)
Read Publication
-
Dr. Ari Rosenberg SINERGY Data Summary
Dr. Ari Rosenberg from the University of Chicago gives a summary on the SINERGY Trial data that he presented during an oral plenary session at MHNCS.
Watch Video
-
Fetal Focus: The next-generation single-gene NIPT enables actionable intervention
Watch Video
-
Prospera Case Study Video- Dr. Lodhi
Watch Video
-
What ASCO GI 2026 Means for Patients: How MRD Research Is Shaping GI Cancer Care
Read Article
-
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study
Ando K, Hamabe A, Nakamura Y, et al. Ann Surg. 2026
Read Publication
-
Utility of Circulating Tumor DNA to Assess Tumor Response in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Therapy
Chakrabarti S, et al. Cancers. 2026
Read Publication
-
Loading More...
